Track Euclidean Capital's Investment Activity
Get real-time alerts when Euclidean Capital makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.
Euclidean Capital
Family office of the late Jim Simons (1938-2024), legendary mathematician and founder of Renaissance Technologies. Simons was often called "the greatest investor on Wall Street" - his Medallion Fund generated 66% average annual returns (39% after fees) from 1988-2018, producing $104.5 billion in profits. Former NSA codebreaker, Stony Brook math chair, and co-author of Chern-Simons theory. Net worth peaked at $31.4 billion. Founded Euclidean Capital 2009 to manage personal wealth. Led by CIO Ashvin Chhabra (former Merrill Lynch CIO). Focus on AI, biotech, life sciences investments. Also funds Simons Foundation ($4B+ in science philanthropy) and Flatiron Institute computational research.
Ripple Foods
Dec 3, 2025
Leal Therapeutics
Aug 27, 2025
SetPoint Medical
Aug 11, 2025
Actio Biosciences
Jun 18, 2025
Zeitview
Mar 5, 2025
13+ more investments
View all 18 deals by Euclidean Capital